CN101677953A - 用于离子电渗疗法的特比萘芬制剂 - Google Patents

用于离子电渗疗法的特比萘芬制剂 Download PDF

Info

Publication number
CN101677953A
CN101677953A CN200880009192A CN200880009192A CN101677953A CN 101677953 A CN101677953 A CN 101677953A CN 200880009192 A CN200880009192 A CN 200880009192A CN 200880009192 A CN200880009192 A CN 200880009192A CN 101677953 A CN101677953 A CN 101677953A
Authority
CN
China
Prior art keywords
terbinafine
pharmaceutical composition
treatment
formulation
nail
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200880009192A
Other languages
English (en)
Chinese (zh)
Inventor
戴利亚·杰亚斯
博阿兹·尼特赞
米凯尔·罗伊兹
戴维·巴拉克
奥里特·肖尔托
雷切尔·莫斯科维茨-西尔弗史密斯
雪莉·杜迪-本-亚科夫
多伦·法尔德曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Power Paper Ltd
Original Assignee
Power Paper Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Power Paper Ltd filed Critical Power Paper Ltd
Publication of CN101677953A publication Critical patent/CN101677953A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CN200880009192A 2007-02-21 2008-02-20 用于离子电渗疗法的特比萘芬制剂 Pending CN101677953A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90234607P 2007-02-21 2007-02-21
US60/902,346 2007-02-21
PCT/IL2008/000218 WO2008102349A2 (en) 2007-02-21 2008-02-20 Terbinafine formulation for iontophoresis

Publications (1)

Publication Number Publication Date
CN101677953A true CN101677953A (zh) 2010-03-24

Family

ID=39590146

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880009192A Pending CN101677953A (zh) 2007-02-21 2008-02-20 用于离子电渗疗法的特比萘芬制剂

Country Status (5)

Country Link
US (1) US20100168233A1 (https=)
EP (1) EP2120870A2 (https=)
JP (1) JP2010519288A (https=)
CN (1) CN101677953A (https=)
WO (1) WO2008102349A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120392664A (zh) * 2025-07-02 2025-08-01 烟台大学 高浓度特比萘芬盐酸盐水溶液的制备方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2526928B1 (en) 2007-02-05 2018-12-26 Biophile Corporation, Ltd Increased effectiveness of allylamine drug compounds
ES2369101B2 (es) * 2010-05-07 2012-08-02 Universidade De Santiago De Compostela Sistema farmacéutico acuoso para la administración de fármacos en las uñas.
US11173163B2 (en) * 2015-08-05 2021-11-16 Cmpd Licensing, Llc Topical antimicrobial compositions and methods of formulating the same
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11446236B2 (en) 2015-08-05 2022-09-20 Cmpd Licensing, Llc Topical antimicrobial compositions and methods of formulating the same
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection
WO2019135123A1 (en) * 2018-01-02 2019-07-11 Nal Pharmaceutical Group Limited Liquid dosage form for topical application
IT201800003557A1 (it) * 2018-03-14 2019-09-14 Kolfarma S R L Preparazione farmaceutica o di integratore alimentare a base di alfa-lattoalbumina

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US238672A (en) * 1881-03-08 Child s-carriage top
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
CN1894001A (zh) * 2003-07-14 2007-01-10 纸型电池有限公司 使用电动传送物质治疗甲癣的方法、装置和药盒
AR045241A1 (es) * 2003-08-12 2005-10-19 Novartis Consumer Health Sa Composicion topica que comprende terbinafina e hidrocortisona
US20050238672A1 (en) * 2004-04-27 2005-10-27 Nimni Marcel E Antifungal drug delivery
WO2006103638A2 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Topical pharmaceutical compositions of terbinafine and processes for their preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120392664A (zh) * 2025-07-02 2025-08-01 烟台大学 高浓度特比萘芬盐酸盐水溶液的制备方法

Also Published As

Publication number Publication date
EP2120870A2 (en) 2009-11-25
WO2008102349A3 (en) 2008-11-06
JP2010519288A (ja) 2010-06-03
WO2008102349A2 (en) 2008-08-28
US20100168233A1 (en) 2010-07-01

Similar Documents

Publication Publication Date Title
CN101677953A (zh) 用于离子电渗疗法的特比萘芬制剂
JP4414517B2 (ja) イオントフォレーシス用デバイス構造体
AU2004255059B2 (en) Method, apparatus, and kit for onychomycosis treatment using electrokinetic transport of substances
JP3224814B2 (ja) 薬剤による皮膚刺激の軽減又は予防
WO2008121709A1 (en) Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug
JP2009542657A (ja) ゲルの形態でのロピニロール含有薬学的組成物、その使用
CN102065807B (zh) 用于曲坦类化合物离子电渗疗法的多胺增强制剂
BRPI0616487A2 (pt) aparato e método de iontoforese para liberação sistêmica de agentes ativos
US7596407B2 (en) Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
CN101022779A (zh) 抗真菌药物的递送
Sachdeva et al. Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin
Amichai et al. Iontophoretic terbinafine HCL 1.0% delivery across porcine and human nails
JP2011503222A (ja) イオン導入による爪疾患の処置のためのアモロルフィンの使用
KR101690765B1 (ko) 항진균성 활성물질을 포함하는 경피 제제
CN112999199A (zh) 酮咯酸氨丁三醇凝胶贴膏的制备及应用
JP4854109B2 (ja) アルカリイオン水を含有する哺乳動物適用の医薬組成物
RU2371179C2 (ru) Чрескожное введение соединений пиперазинил-2 (3н)-бензоксазолона посредством электрофореза
CN113274500A (zh) 神经激肽1受体抑制剂的外用制剂及其制备方法
S Vaghani et al. Effect of iontophoresis and permeation enhancers on the permeation of an acyclovir gel
Ansari et al. Iontophoretic drug delivery systems
US20080234629A1 (en) Water electrolysis to facilitate drug delivery by iontophoresis
Shah et al. CHALLENGES AND NOVEL APPROACHES FOR THE TREATMENT OF ONYCHOMYCOSIS
CN109602911B (zh) 硫酸钙晶须或其组合物在制备皮肤促渗剂中的用途
CN101203215A (zh) 用于治疗上皮疾病的神经节阻断药
MXPA06011018A (en) Transdermal iontophoretic delivery of piperazinyl-2(3h)-benzoxazolone compounds

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20100324